News Focus
News Focus
Followers 258
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: farrell90 post# 73152

Friday, 10/10/2014 3:05:59 AM

Friday, October 10, 2014 3:05:59 AM

Post# of 405212
I agree. I see something more like Roche or AstraZeneca who are actively buying biopharma technology and investing in R&D.

I do not believe Cubist is large enough.

Cubist may be more likely to be Brilacidin's victim than partner.


“It is difficult to get a man to understand something, when his salary depends on his not understanding it.”
-- Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y